Kura Oncology | ARS: Annual Report to Security Holders
Apr 18 16:09 ET
Kura Oncology | DEF 14A: Definitive information statements
Apr 12 16:29 ET
Kura Oncology | DEFA14A: Others
Apr 12 16:29 ET
Kura Oncology | UPLOAD: Others
Feb 29 15:09 ET
Kura Oncology | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Feb 27 16:59 ET
Kura Oncology | 10-K: Annual report
Feb 27 16:14 ET
Kura Oncology | 8-K: Kura Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
Feb 27 16:09 ET
Kura Oncology | 424B3: Prospectus
Feb 15 16:03 ET
Kura Oncology | EFFECT: Others
Feb 15 06:11 ET
Kura Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(9.99%),Oleg Nodelman(9.99%), etc.
Feb 14 18:03 ET
Kura Oncology | CORRESP: CORRESP
Feb 14 15:09 ET
Kura Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BVF Partners L.P.(9.9%),BVF Inc.(9.9%), etc.
Feb 14 09:43 ET
Kura Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.44%)
Feb 13 22:47 ET
Kura Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Suvretta Capital Management, LLC(9.99%),Aaron Cowen(9.99%), etc.
Feb 13 17:34 ET
Kura Oncology | CORRESP: CORRESP
Feb 13 15:09 ET
Kura Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deerfield Mgmt, L.P.(7.15%),Deerfield Management Company, L.P.(7.15%), etc.
Feb 12 17:36 ET
Kura Oncology | S-3: Registration statement for specified transactions by certain issuers
Feb 9 17:25 ET
Kura Oncology | D: Filing D
Feb 5 14:14 ET
Kura Oncology | 4: Statement of changes in beneficial ownership of securities-Officer DOYLE THOMAS JAMES
Jan 31 17:33 ET
Kura Oncology | 4: Statement of changes in beneficial ownership of securities-Officer FORD KATHLEEN
Jan 31 17:33 ET
No Data
No Data